1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6EA431438F71E090E00258D030055EDF7
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/activating-medicals-customers-investment-performance-channels-content
18
19
20216.73.216.126
21
22
23globalbenchmarking.com
24/bestp/domrep.nsf
25BMR




» Products & Services » » Medical Affairs » Structure, Staffing and Budgets

Activating Your Customers: Optimize Medical’s Investment and Performance with the Channels and Content that Matter

ID: POP-411


Features:

16 Info Graphics

25 Data Graphics

380+ Metrics

20 Narratives


Pages: 49


Published: 2025


Delivery Format: Shipped


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
This report provides current performance metrics and strategic insights to help Medical Affairs executives optimize engagement, elevate content effectiveness, and align investment with organizational goals. The findings will enable leaders to build scalable, customer-centric engagement models that boost activation, maximize ROI, and position Medical as an indispensable strategic partner driving treatment uptake and business growth.

Medical Affairs leaders are increasingly challenged to demonstrate strategic value through precise, data-driven engagement across a rapidly evolving stakeholder landscape. As traditional models give way to digital-first strategies, Medical Affairs teams must rethink their channel mix, content strategy, and investment priorities to activate high-value customer segments and deliver measurable impact.

Developed by Best Practices, LLC, this benchmarking research uncovers how Medical Affairs is advancing beyond face-to-face interactions to embrace omnichannel systems, AI-powered content creation, and targeted outreach to rising stakeholder groups such as Digital Opinion Leaders (DOLs), Advanced Practice Providers (APPs), and advocacy organizations. Yet, despite these advances, only a small percentage of companies report yet achieving high-impact omnichannel maturity—highlighting a critical gap and growth opportunity for most Medical Affairs groups across the industry.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Manufacturing; Diagnostic; Health Care; Service; Medical Device; Clinical Research; Laboratories


Companies Profiled:
AbbVie; Alnylam Pharmaceuticals; AstraZeneca; Axsome Therapeutics; Biogen; bioMérieux; BIOVIIIx; Boehringer Ingelheim; Eisai; EMD Sereno; EVERSANA; Exact Sciences; ImmunityBio; Ipsen; Jazz Pharmaceuticals; Johnson & Johnson; Lantheus; Merck & Co.; Merck KGaA; Organon; Orion Pharmaceuticals; Otsuka; Premier Research; Relay Therapeutics; Sanofi; Sobi; Stallergenes Greer; Taiho Oncology; Vertex Pharmaceuticals; Xenon Pharmaceuticals

Study Snapshot

Best Practices, LLC engaged 31 Medical Affairs leaders from 30 biopharma companies. The research team also conducted deep-dive interviews with select participants to capture additional insights on how Medical teams are advancing engagement, content, and investment strategies.

Key topics covered in this report include:

  • Medical Affairs Channel Mix and Investment Strategy
  • Customer Segmentation and Activation
  • Content Creation and Deployment Trends
  • Omnichannel Maturity and Integration
  • Performance Measurement and KPIs

Key Findings

Select key insights uncovered from this report are noted below. Detailed findings are available in the full report.

  • Digital Engagement Is Redefining Stakeholder Strategy: Medical Affairs teams are expanding beyond KOL-centric models to engage non-traditional stakeholders—particularly Advanced Practice Prescribers (APPs), Digital Opinion Leaders (DOLs), and advocacy groups. These segments are increasingly influential in care decisions and require digital-first approaches such as chatbots, plain language content, and on-demand medical information portals.
  • AI Is Reshaping Content Creation and Delivery: AI is increasingly embedded in the content lifecycle—from audience analysis and topic selection to video production and impact measurement. Many organizations are transitioning from vendor-supported pilots to insourced AI-driven content hubs, enabling faster, more personalized stakeholder engagement.
Table of Contents

Sr. No.
Topic
Slide No.
I. Executive SummaryPg. 5
II. High-Impact Engagement: Channel Mix, Key Segments & Strategies to Activate CustomersPg. 14
III. Efficient Content Creation and Effective DeploymentPg. 27
IV. Insights & Integrated EngagementPg. 40
V. Participant DemographicsPg. 46
VI. About Best Practices, LLCPg. 49

    List of Charts & Exhibits

    I. Executive Summary

    • One-page executive summary
    • Participating benchmark companies
    • Executive takeaways from the study
    • Medical Engagement Analyzer: Strategic priorities for Medical Affairs engagement
    • Strategically important engagement channels
    • Key customer segments with growing strategic importance
    • Multi-factor strategy for content selection
    • Content development and deployment trends
    • Omnichannel advancement

    II. High-Impact Engagement: Channel Mix, Key Segments & Strategies to Activate Customers

    • Medical’s current state of external engagement
    • Medical’s current state of external engagement – Large pharma vs. mid-small pharma segment
    • Strategic importance of engagement channels, as determined by engagement potential, ability to fulfill medical strategy, and provide business value
    • Success stories around activating medical customers
    • New KPIs used to measure engagement
    • Average Medical Affairs spend level by channel
    • Medical Affairs channels spend mix – Large pharma vs. mid-small pharma segment
    • Peer success stories in engagement –Targeted innovations for more engagement
    • Peer success stories in engagement –Targeted innovations for better activation / pull-through
    • Peer success stories in engagement –Targeted innovations for higher reach / frequency
    • Emerging customer segments for Medical’s launch strategy

    III. Efficient Content Creation and Effective Deployment

    • Content creation – internal vs. external usage
    • Top content for training and internal enablement
    • Top content for scientific exchange and engagement
    • Innovative content for scientific exchange and engagement
    • Data-driven content creation
    • Multi-factor strategy for content development
    • AI-driven content creation for impactful engagement
    • Average medical FTEs dedicated to content creation
    • Average medical FTEs dedicated to content creation – Large pharma vs. mid-small pharma segment
    • Reusable vs. single-use content
    • Content strengths and weaknesses across organizations
    • Content strengths and weaknesses across organizations – Large pharma vs. mid-small pharma segment

    IV. Insights & Integrated Engagement

    • Integrated omnichannel coordination and insight sharing
    • Integrated omnichannel coordination and insight sharing – Large pharma vs. mid-small pharma segment
    • Omnichannel engagement curve
    • Omnichannel maturity levels – Large pharma vs. mid-small pharma segment
    • Peer innovations in omnichannel strategy

    V. Participant Demographics

    • Therapeutic areas represented in the study
    • Geographic coverage of benchmarked Medical Affairs roles